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Current assays used to detect Mycobacterium bovis infection lack accuracy, especially for recently infected
animals, or are impractical for rapid field diagnostic applications. To overcome these limitations with sero-
logical assays, a synthetic peptide derived from early secretory antigenic target 6 (ESAT6-p) and a recombinant
major secreted immunogenic protein (rMPB70) of M. bovis were used in an enzyme-linked immunosorbent
assay (EIA), an immunochromatographic assay (ICGA), and a latex bead agglutination assay (LBAA). Sera
from noninfected, M. bovis-infected, or M. avium subsp. paratuberculosis-infected (by natural and experimental
routes) animals were evaluated. Receiver operating characteristic analysis comparing optical density values
from the EIA with results of bacterial culture or skin test, the reference test, established suitable cutoff values
for assessing sensitivity and specificity. The EIA and LBAA, respectively, had sensitivities of 98.6 and 94.8%,
specificities of 98.5 and 92.6%, and kappa values of 0.97 and 0.88 with ESAT6-p. The EIA, ICGA, and LBAA,
respectively, had sensitivities of 96.8, 83.0, and 86.7%, specificities of 90.1, 99.4, and 97.8%, and kappa values
of 0.87, 0.85, and 0.83 with rMPB70. Examination of serial samples of sera collected from experimentally M.
bovis-infected cattle and deer revealed that ESAT6-p-specific responses developed early after infection whereas
responses to rMPB70 developed later in the course of disease. The advantage of the LBAA and ICGA as initial
tests for multiple species is a rapid reaction obtained in 2 to 3 h by LBAA or 20 min by ICGA without
species-specific secondary antibodies under field conditions, thus allowing immediate segregation of suspect
animals for further testing before culling.
Bovine tuberculosis (bTB) is caused by Mycobacterium bovis,
a member of the Mycobacterium tuberculosis complex. bTB is
one of the important bovine diseases causing great economic
loss worldwide (21, 30). These are also diseases of concern for
other ruminant species and humans (8, 21). The presence of M.
bovis in wild-animal reservoirs (21, 23, 32, 38, 49) has also
made control of the diseases more difficult.
At present, the standard diagnostic assay for bTB is the
single intradermal (SID) test (skin test) with purified protein
derivative (PPD). There are many limitations to the SID test
and other cell-mediated immunity (CMI)-based tests (e.g.,
gamma interferon [IFN-] and lymphocyte proliferation as-
says) for the diagnosis of bTB. The first limitation is that the
delayed-type hypersensitivity response to the antigen has low
sensitivity and specificity. It is not possible to determine if the
response to PPD is attributable to exposure to M. bovis, M.
avium subsp. paratuberculosis, or environmental mycobacteria,
e.g., Mycobacterium avium subsp. avium. Second, there is a
predominant CMI response during the early phases of infec-
tion with low bacillary loads which may be reduced or absent in
animals at the advanced stages of disease with high bacterial
loads. The animals become anergic to CMI-based tests (18, 35,
42, 46). Third, animals need to be handled twice over a 72-h
period to obtain results of the test. Fourth, other CMI-based
tests are expensive and require trained staff to perform the
tests and interpret the results. Fifth, false positives may result
from exposure to environmental mycobacteria and/or vaccina-
tion with BCG. Therefore, there is a need to develop sensitive
and easy-to-use M. bovis-specific serological tests that can be
used to distinguish between animals exposed to M. bovis, M.
avium subsp. paratuberculosis, and environmental mycobacte-
ria.
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The currently available serological assays developed for herd
testing have low sensitivity and suboptimal specificity (7, 35,
47), probably due to the use of complex bacterial extracts
containing antigens expressed by pathogenic and environmen-
tal mycobacteria. It is possible that diagnostic assays can be
improved by using antigens unique to the pathogen. Further
improvement may also be achieved by the use of different
diagnostic techniques. As an example, ongoing studies have
shown that a latex bead agglutination assay (LBAA) has con-
siderable potential. Increased sensitivity and specificity have
been obtained with latex beads coated with ESAT6-p, a pep-
tide containing the immunodominant portion of ESAT-6
(early secretory antigenic target) (25), a protein secreted dur-
ing the early or active phase of mycobacterial infection. The
antigen is not present in M. avium subsp. paratuberculosis, and
the gene encoding it has been deleted in BCG (9, 52, 57, 58).
Since the LBAA needs only serum, latex beads conjugated with
ESAT6-p, and phosphate-buffered saline (PBS) as a diluent, it
can be used to diagnose bTB in any species.
Another protein with potential for use in the LBAA and
other assays is MPB70, a major secreted immunogenic protein
component of tuberculin (18). It is another protein present in
M. bovis culture filtrates (11, 12, 16, 34). High sensitivity and
specificity have been reported in tests where the antigen was
used in an enzyme-linked immunosorbent assay (EIA) and a
fluorescence polarization assay (13, 14, 18, 28, 46, 55, 56, 63).
The objective of the present study was to compare the sensi-
tivity and specificity of the LBAA with the EIA using ESAT6-p
or a recombinant form of MPB70 (rMPB70) containing T- and
B-cell epitopes (4, 18, 28, 33, 37, 43, 48). The activity of
rMPB70 was also examined for use in a commercial EIA and
an immunochromatographic assay (ICGA) under patent ap-
plication after development (Animal Genetics Inc., Suwon,
South Korea). The results reported here show that the LBAA
and ICGA with M. bovis-specific antigens offer an approach to
the development of rapid diagnostic assays for use in the dif-
ferential diagnosis of bTB caused by M. bovis and Johne’s
disease caused by M. avium subsp. paratuberculosis.
MATERIALS AND METHODS
Animals. Three different groups of bovine and cervine sera were used in this
study as follows.
M. bovis-infected cattle and deer. Sera from naturally or experimentally M.
bovis-infected cattle (n  300 and n  20, respectively) were used as in previous
studies (25, 40). Briefly, sera were obtained from 300 cows within 10 days after
a positive SID test (over 5-mm skin thickness) was observed in animals surveyed
in the national herd check program. Documentation of infection with M. bovis
was verified by culture of M. bovis from intestinal tissue or nasal and tracheal
mucus obtained at the time of necropsy. Additionally, sera were obtained from
20 calves (5 calves in each of four groups) experimentally infected by aerosol
challenge with either of two different isolates of M. bovis, one from white-tailed
deer (1315) and the other from cattle (HC2005T) (40). Experimental infection of
M. bovis was confirmed in 19 calves by the tuberculin skin test, isolation of M.
bovis, and gross or microscopic tuberculous lesions in the lungs and tracheo-
bronchial and mediastinal lymph nodes at the time of necropsy.
Experimental infection of four deer with M. bovis was performed by intraton-
sillar instillation of 2 108 CFU of M. bovis strain 1315. Sera from the deer were
collected over a 10-month period preinfection and postinfection (p.i.) (1 week
preinfection and 90, 119, 228, 252, and 309 days p.i.) (39). Infection was con-
firmed in all four deer by a positive tuberculin skin test, isolation of M. bovis from
nasal secretions and saliva, and gross or microscopic disseminated tuberculous
lesions in the lungs and tracheobronchial and mediastinal lymph nodes at the
time of necropsy.
The skin test was done at 57 and 123 days postexposure to M. bovis in the
aerosol-infected calves (40) and at 96 and 225 days p.i. in the intratonsillarly M.
bovis-infected deer (39).
M. avium subsp. paratuberculosis-infected cattle. Sera collected from naturally
and experimentally M. avium subsp. paratuberculosis-infected cattle (n 149 and
n  8, respectively) were used as controls in the diagnostic assays as described in
previous reports (25, 61). Infection with M. avium subsp. paratuberculosis was
verified by clinical signs of advanced paratuberculosis or by use of the
PARACHEK, Johne’s Absorbed EIA (CSL Veterinary, Parkville, Victoria, Aus-
tralia) and the isolation of M. avium subsp. paratuberculosis from the intestine at
necropsy or analysis of the immune response to M. avium subsp. paratuberculosis
antigens in the eight experimentally infected calves (26, 61).
Since all of the M. avium subsp. paratuberculosis-positive cattle were confirmed
to be free of M. bovis by bacterial culture and PCR with intestinal tissue or fecal
samples, the sera were included in this study to demonstrate that there were no
cross-reactive antibodies present in sera from M. avium subsp. paratuberculosis-
infected cattle.
M. bovis- and M. avium subsp. paratuberculosis-free animals. Additional con-
trol sera were obtained from healthy animals including 155 cows in the Wash-
ington State University dairy herd and the Seoul National University dairy herd
that were free of M. bovis and M. avium subsp. paratuberculosis and four deer
used in a previous study (39).
Preparation of ESAT6-p- and recombinant MPB70 protein (rMPB70)-conju-
gated latex beads. Polystyrene microspheres with vinyl carboxylic acid (nearly
soap free, 0.85 m) from Bangs Labs Inc. (Fishers, Ind.) and the synthesized
peptide (31) of ESAT-6 (KGSGSMTEQQWNFAGIEAAASAIQG) known to
contain an epitope recognized by antibodies from infected animals (15, 53) were
used for this study (25). An extra lysine, an extra glycine, and an extra serine were
added to the N-terminal end of ESAT6-p to make an amide bond with the
carboxylate groups on the beads (20).
Three kinds of rMPB70 were obtained from Animal Genetics Inc. (Suwon,
South Korea) for use in this study: (i) purified rMPB70 for use as a capture
antigen on the EIA plate, (ii) rPBM70 conjugated to colloidal gold for use as a
detector reagent in the conjugate pad of the ICGA device, and (iii) rMPB70 used
to coat the formatted test line in an ICGA device.
Different concentrations of ESAT6-p or one of the three kinds of rMPB70
were conjugated to beads using the following protocol and then tested for the
capacity to agglutinate in the presence of sera from M. bovis-infected cattle. To
conjugate the beads with ESAT6-p or rMPB70, the beads were washed four
times, resuspended in an activation buffer (2-morpholinoethanesulfonic acid,
monohydrate [pH 5.2]), and then activated by mixing with 10 mM 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (Sigma) and 5 mM sulfo-N-
hydroxysuccinimide (Sigma) (54). After mixing for 30 min on a rotating wheel,
the beads were washed and resuspended in coupling buffer (borate buffer, pH
8.5) and then reacted with different concentrations of ESAT6-p dissolved in
dimethyl sulfoxide or rMPB70 dissolved in water. The bead mixture was placed
on the rotating wheel and mixed for 18 h at room temperature, resuspended in
a blocking solution (10 mM glycine), and then mixed for an additional 30 min. In
the final step, the beads were washed and then incubated for 3 h at room
temperature in cold PBS (pH 7.2) containing 1% bovine serum albumin and
0.05% Tween 20. The conjugated beads were stored at 4°C until used.
To standardize the assay, a checkerboard array was used in 96-well round-
bottom tissue culture plates, with different concentrations of conjugated beads
(50 l/well in PBS) mixed with different concentrations of sera (50 l/well) from
uninfected control and M. bovis-infected animals. After determining the optimal
conditions for obtaining M. bovis antigen-specific agglutination, the LBAA was
conducted with serial dilutions of sera from control animals and animals infected
with M. avium subsp. paratuberculosis or M. bovis.
EIA with ESAT6-p. To compare the sensitivity and specificity of the EIA with
M. bovis culture and the skin test, the reference test for the diagnosis of bTB, an
EIA was developed with ESAT6-p and standardized by checkerboard titration to
determine the optimal concentration of ESAT6-p and serum to use in the assay
(25). After developing the EIA, the assay was performed and replicated on the
same day with the use of the same sera from three healthy control cows, three M.
avium subsp. paratuberculosis-infected cows, and three M. bovis-infected cows in
each EIA plate to determine the intra- and interassay variations of optical
density (OD) values and minimize any possible variations due to the use of
different plates and performance of the assay on different days. Detailed proto-
cols for the EIA with ESAT6-p were exactly followed as those in a previous study
(25).
EIA and ICGA kit with rMPB70. The EIA kit and the ICGA kit using rMPB70
as the capture or conjugated antigen have been in the process of patent appli-
cation after development at Animal Genetics Inc. Those two kits use the direct
sandwich method for antibody capture by using rMPB70 with different carriers or
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epitopes. In the EIA kits, one kind of rMPB70 antigens has been used to coat the
plate and another rMPB70 conjugated with enzyme is used instead of a second-
ary antibody against a specific isotype following the application of sample serum.
In the ICGA platform, anti-MPB70 antibody within sample serum can be cap-
tured on an rMPB70 antigen-colloidal gold complex which is wicked through the
sample pad and then trapped at a test line band containing rMPB70. If no
anti-MPB70 antibody is bound to the antigen-colloidal gold complex, the com-
plex passes through to a second control band containing a goat anti-MPB70
polyclonal antibody, where it is trapped. Two bands will appear in the ICGA
exposed to sera containing anti-MPB70 antibodies. One band will appear in the
ICGA exposed to sera containing no anti-MPB70 antibodies.
Any kind of rMPB70 antibody isotype from any species can be detected, as a
specific secondary antibody is not used to develop the conjugate-enzyme complex
(EIA) or to capture an antigen in a test line (ICGA). The protocols for the two
kits, provided by the company, were followed exactly. In brief, EIA plates coated
with rMPB70 were incubated with 50 l of serum (sample and positive and
negative control sera in the kit) diluted in 100 l of diluent buffer and incubated
at 37°C for 1 h, washed, and then reacted with 100 l of diluted rMPB70-enzyme
conjugate solution at 37°C for 30 min. Following washing, plates were incubated
with 100 l of diluted substrate solution at room temperature for 30 min and
then 100 l of stop solution was added to stop color development. Absorbance
was read at 450 nm with 620 nm as the reference wavelength. For the ICGA kit,
20 l of serum and 3 drops of diluent were applied to the sample pad. Results
were recorded after 5 to 20 min as positive if the test and control lines were
visible on the test pad and negative if only the control line was visible.
Data analysis. Suitable cutoff values for the EIA were determined by receiver
operating characteristic (ROC) analysis (3) based on the results obtained with
the reference tests composed of bacterial culture and the skin test. The agree-
ment between the positive or negative results obtained with the reference tests,
the LBAA, the ICGA, and the EIA was determined by the correlation rate (CR)
(51) or the kappa value from the kappa test (1). Additionally, the statistically
significant association between different assays was confirmed by the chi-square
test (50). The correlation between the OD value from the EIA and the intensity
of agglutination or the test line band from the LBAA or ICGA was determined
by the correlation coefficient from Spearman rank correlation analysis (6). All
statistical analyses were carried out with commercially available (Analyze-it)
software.
RESULTS
Standardization of the LBAA. Testing of the three kinds of
rMPB70 which are used as the capture antigen in the EIA
(purified rMPB70), the antigen-colloidal gold complex, or the
capture antigen in the test line in the ICGA revealed that the
antigen-colloidal gold complex caused background agglutina-
tion due to the reaction between the beads and the antigen-
colloidal gold complex. The third antigen, the capture antigen
used in the ICGA, made stronger agglutination with M. bovis-
positive sera compared with the purified antigen. This form of
rMPB70 was selected as the optimal antigen for use in the
LBAA. Testing of latex beads coated with different concentra-
tions of ESAT6-p or rMPB70 showed that conjugation of 1 mg
of beads with 45 g of ESAT6-p or 43.56 g of rMPB70 was
the best for obtaining specific agglutination, with no aggluti-
nation evident with sera from M. bovis-negative control ani-
mals (25). Examination of plates over a 4-h period revealed
that agglutination was evident with all test sera by 2 to 3 h.
There was no change in the patterns of agglutination when the
plates were incubated overnight at 4°C.
Comparison of sensitivity and specificity. After determining
the optimal conditions for agglutination with latex beads con-
jugated with ESAT6-p or rMPB70, sera from naturally and
experimentally M. bovis-infected cows and deer were tested at
five dilutions (1/5, 1/10, 1/20, 1/40, and 1/80) along with sera
from M. bovis-negative animals. Consistent results were ob-
tained using a dilution of 1/10 to 1/20 for LBAA with ESAT6-p
and rMPB70. The intensity of agglutination was calculated and
analyzed in 10 fields of 1 mm2 randomly selected in wells of the
LBAA (41) with the image analyzer (Olympus, Melville, N.Y.)
and Optimas 6.5 programs. Agglutination was stronger with
some sera than others, and agglutination levels of 0 to 25%, 26
to 50%, 51 to 75%, and 76 to 100% were categorized as 1,
2, 3, and 4 (positive), respectively (25). Although back-
ground agglutination was noted at higher concentrations of
serum with some infected animals, little agglutination was ev-
ident with the test sera from control animals. In the same way
as in the LBAA, the intensity of the test line band in the ICGA
FIG. 1. ROC curves for EIA with ESAT6-p (A) or rMPB70 (B).
Sensitivity and specificity, respectively, were calculated as the number
of serum samples showing positive results by the reference test and the
EIA at each cutoff value divided by the number of reference test
positive results and as the number of serum samples showing negative
results by the reference test and the EIA at each cutoff value divided
by the number of reference test negative results, based on the results
of M. bovis culture or a skin test as the reference test and a comparison
of those two tests (reference test versus EIA).
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was also analyzed and categorized as 1, 2, 3, or 4
(positive).
To compare sensitivity and specificity between the different
assay formats and between assays using ESAT6-p and
rMPB70, the same sera were first tested in the EIA (both
antigens) and ICGA (rMPB70 only) formats. When the ODs
of all the sera from cattle and deer were applied to ROC
analysis (Fig. 1-A), the ROC curve from the EIA with
ESAT6-p had an area under the concentration-time curve
(AUC) of 0.995 (95% confidence interval [CI], 0.990 to 1.000,
P 0.01) and a standard error (SE) of the AUC of 0.0027. For
the EIA with rMPB70, the AUC and SE were 0.980 (95% CI,
0.970 to 0.989, P  0.01) and 0.0047, respectively (Fig. 1B).
Among different cutoff values from the ROC analysis, 0.5 and
0.045 were selected because sensitivities of 98.6 and 96.8% and
specificities of 98.5 and 90.1% were optimal for the EIA with
ESAT6-p and rMPB70, respectively. All the cervine sera from
the four experimentally M. bovis-infected deer and 293 out of
324 bovine sera from naturally or experimentally M. bovis-
infected cattle showed ODs greater than the selected cutoff
values in the EIA with rMPB70 (Table 1). Out of M. bovis-
positive sera from cattle and deer, only four sera from aerosol
M. bovis-challenged calves were negative in the EIA with
ESAT6-p.
Serological assays with rMPB70 and ESAT6-p for bTB
showed similar sensitivities (96.8, 83.0, and 86.7% for the EIA,
ICGA, and LBAA using rMPB70, respectively, and 98.6 and
TABLE 1. Overall serological responses of sera from naturally or experimentally M. bovis- or M. avium subsp. paratuberculosis-infected or
-free cattle or deer in an EIA, an ICGA, or an LBAA utilizing rMPB70 or ESAT6-p as the coating or conjugating antigena
Antigen and
assay
No. of positive sera/no. testedd












Naturally infectedc Experimentallyinoculated Total
rMBP70
EIA 272/300 (90.7) 17/20 (85.0) 289/320 (90.3) 4/4 (100) 293/324 (96.8) 5/155 (96.8) 1/157 (99.4) 6/312 (90.1)
ICGA 248/300 (82.7) 18/20 (90.0) 266/320 (83.1) 3/4 (75.0) 269/324 (83.0) 2/155 (98.7) 0/157 (100) 2/312 (99.4)
LBAA 259/300 (86.3) 18/20 (90.0) 277/320 (86.6) 4/4 (100) 281/324 (86.7) 5/155 (96.8) 2/157 (98.7) 7/312 (97.8)
ESAT6
EIA 300/300 (100) 16/20 (80.0) 316/320 (98.8) 4/4 (100) 320/324 (98.6) 4/155 (97.4) 4/155 (97.4) 4/312 (98.5)
LBAA 283/300 (94.3) 20/20 (100) 303/320 (94.7) 4/4 (100) 307/324 (94.8) 15/155 (90.3) 15/155 (90.3) 23/312 (92.6)
a The group of M. bovis-infected animals (n  324) included cattle (n  320) (both naturally infected cows [n  300] and experimentally inoculated calves [n  20]
and experimentally inoculated deer (n  4). Values in parentheses are sensitivities (given as percentages).
b The group of M. bovis-free animals (n  312) included both M. avium subsp. paratuberculosis-free animals (n  155) and M. avium subsp. paratuberculosis-infected
cattle (n  157). Values in parentheses are specificities (given as percentages).
c Natural M. bovis infection was checked by the SID test (over 5-mm skin thickness after the test) and culture of M. bovis from intestinal tissue or nasal and tracheal
mucus at the time of necropsy.
d Detailed information on how natural M. bovis or M. avium subsp. paratuberculosis infection was confirmed, how M. bovis or M. avium subsp. paratuberculosis was
inoculated experimentally, and how a positive response in the EIA, LBAA, or ICGA was defined is given in Materials and Methods. Although one M. bovis-inoculated
calf with NVL and three deer at the NVL stage (90 days p.i.) were negative by M. bovis culture, their sera showed a positive response with ESAT6-p by the EIA and
LBAA, and serum from one NVL calf also reacted positively with rMPB70 by the LBAA. The specificity of the EIA with ESAT6-p or rMPB70 was also affected because
the specificity of the EIA was calculated by comparing the result of bacterial culture or a skin test with that of the EIA by ROC analysis with the Analyse-it program.
The EIA and the ICGA kit using rMPB70 were obtained from Animal Genetics Inc. (Suwon, South Korea), and the other assays (the EIA with ESAT6-p and the
LBAA) were developed in this study.
TABLE 2. Comparison of the diagnostic tests used in this study
Test or antigen
and assay
CR or K value (2 value)a
Culture or skin test
ESAT6-p rMPB70
EIA LBAA EIA LBAA ICGA
Culture or skin test 0.97 (628.57) 0.88 (510.73) 0.87 (510.62) 0.85 (480.72) 0.83 (469.80)
ESAT6-p 0.88 (514.18)
EIA 98.7 0.86 (493.47) 0.84 (470.87) 0.81 (446.73)
LBAA 93.9 94.0 0.77 (396.96) 0.75 (382.91) 0.74 (373.49)
rMPB70
EIA 93.7 92.9 83.5 0.74 (358.01) 0.91 (557.06)
LBAA 92.4 91.9 87.7 87.0 0.70 (321.33)
ICGA 91.6 90.6 87.0 95.8 85.2
a CRs (percent) are in boldface type. The K values and 2 values were obtained by chi-square analysis performed to evaluate the agreement between a positive or
negative result of a bacterial culture or skin test, an EIA, an LBAA, and an ICGA with ESAT6-p or rMPB70. According to the chi-square analysis, all of the assays
used in this study are statistically significantly associated with each other (P  0.0001).
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94.8% for the EIA and LBAA with ESAT6-p, respectively;
Table 1).
The CRs (51), the kappa () values from the kappa test (1),
and the 2 values from the chi-square analysis (50) were cal-
culated to evaluate the agreement between the positive and
negative results obtained with the reference test, the LBAA,
the ICGA, and the EIA (Table 2). After Spearman rank cor-
relation analysis (6), the correlation coefficient (r) between the
OD value from the EIA and the intensity of agglutination in
the LBAA was 0.73 (95% CI, 0.70 to 0.77, P  0.0001) for
ESAT6-p and 0.68 (95% CI, 0.64 to 0.72, P  0.0001) for
rMPB70 (Fig. 2A and B). The intensity of the test line band in
the ICGA was also highly correlated with the OD value from
the EIA utilizing rMPB70 with an r of 0.87 (95% CI, 0.85 to
0.88, P  0.0001) (Fig. 2C).
The assays with rMPB70 detected M. bovis-positive sera that
were negative in the ESAT6-p assays. With the sera collected
four or five times, monthly or bimonthly, from experimentally
M. bovis-infected calves and deer, assays utilizing ESAT6-p
could detect antibody activity against M. bovis in samples col-
lected at earlier time points compared with assays with
rMPB70 (Tables 3 and 4; Fig. 3). None of the sera from the
preinfection stage of cattle and deer experimentally infected
with M. bovis showed a positive reaction in the EIA, LBAA, or
ICGA.
DISCUSSION
In the early or active phase of infection, the metabolically
active mycobacteria secrete proteins such as ESAT-6 and
CFP10 antigens, which were originally identified in culture
filtrates of M. tuberculosis containing highly immunogenic low-
molecule-mass proteins. The genes encoding these proteins
are located in the same operon (9, 52). The antigens elicit a
strong antibody response and induce secretion of IFN-. The
response to these antigens has been found in recent converters
to PPD positivity and in tuberculosis patients but not in BCG-
vaccinated or unvaccinated individuals (57). ESAT-6 (6 kDa) is
virtually specific for the M. tuberculosis complex; the gene is
present in all isolates of M. tuberculosis and virulent M. bovis,
but it is absent from all strains of BCG (52). Therefore,
ESAT-6 and CFP10 can be potential candidates for use in
early detection as substitutes or as improved skin test antigens
(58). In particular, ESAT-6 is an important T-cell antigen
recognized by protective T cells in early stages of M. tubercu-
losis infection in an animal model (52). A monoclonal anti-
body, HYB76-8, has been known to be specific to two peptides
(p1-20 and p12-35) in the N-terminal region of the ESAT-6
protein in which p1-20 peptides (MTEQQWNFAGIEAAASA
IQG) most strongly react with the monoclonal antibody (15,
17). As a result, high specificity could be achieved by using
synthetic ESAT6-p containing sequences from native proteins
known to contain an epitope recognized by antibodies in sera
from infected animals.
MPB70 is one of the immunodominant antigens of M. bovis
(11, 12). It is an extremely stable and active component of
bovine tuberculin (18). Skin testing with tuberculin boosts the
immunoglobulin G1 antibody responses to MPB70 (28), par-
ticularly antibody recognizing the epitope within residues 51 to
70 of MPB70 in skin test-positive cattle. This memory response
FIG. 2. Spearman rank correlation analysis between OD values
from the EIA and the intensity of agglutination from the LBAA uti-
lizing ESAT-6 (A) or rMPB70 (B) and between OD values and the
intensity of the test line band from the ICGA with rMPB70 (C). The
EIA and LBAA turned out to be positively correlated (P  0.0001),
with r  0.73 (95% CI, 0.70 to 0.77) or 0.68 (95% CI, 0.64 to 0.72)
when using ESAT-6 or rMPB70 as the detecting antigen, respectively.
A statistically significant correlation between the ICGA and EIA uti-
lizing rMPB70 was also found, with r  0.87 (95% CI, 0.85 to 0.88, P
 0.0001).
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has been found in M. bovis-infected cattle with macroscopic
and tuberculous lesions (27). It is able to elicit a strong de-
layed-type hypersensitivity response and to stimulate T-lym-
phocyte proliferation and antibody production in M. bovis-
infected animals (10, 11, 16, 18, 19, 43). Effective DNA
vaccination of cattle with mycobacterial antigens MPB83 and
MPB70 does not compromise the specificity of the compara-
tive intradermal tuberculin skin test (60). Moreover, a plasmid
expressing MPB70 has been shown to be a better therapeutic
vaccine in mice than a plasmid expressing hsp65, particularly
against the growth of bacteria in the lung (29).
For the development of simple and easy-to-use agglutination
assays, latex bead technology has been used successfully (24,
36, 59, 64, 65). Similarly, recombinant or synthetic peptides
derived from species-specific M. bovis proteins containing
epitopes recognized by antibodies from infected animals can
be used singly or multiplexed on a lysine polymer backbone
using currently available technology to detect antibodies spe-
cific for M. bovis (22).
Comparisons between the reference test and the assays used
or developed in this study were made by calculating the CR, 
value, and r after Spearman rank correlation analysis and con-
firmed by chi-square analysis (Fig. 2; Table 2). Comparison of
the reference test and assays with ESAT6-p gave  values of
0.97 and 0.88 and CRs of 98.7 and 93.9% for the EIA and
LBAA, respectively (P  0.0001) (Table 2). The high values of
 and CR indicate that EIA and LBAA with ESAT6-p can be
used as reliable methods for detection of animals infected with
M. bovis. Results with the prototype of the EIA and ICGA
utilizing rMPB70, developed at Animal Genetics Inc., yielded
results very similar to those obtained with the reference test (
values of 0.87 and 0.83 and CRs of 93.7 and 91.6%, respec-
tively). The LBAA with rMPB70 showed a K value (0.85) and
CR (92.4%) comparable to those of the two kinds of prototype
assays. This means that the LBAA utilizing rMPB70 has a
similar sensitivity, and it can be used as well as the prototype
assays from Animal Genetics Inc. for the diagnosis of bTB.
Serial samples of sera collected at pre- and postinfection
were applied to the EIA, ICGA, and LBAA to determine how
early an antibody response to ESAT6-p and rMPB70 can be
detectable and how its dynamic changes occur at different
stages of M. bovis infection (Tables 3 and 4; Fig. 3). Although
all of the preinfection sera were negative in the EIA and
LBAA, 80%, 90%, and 90% of the bovine sera collected at 27,
78, and 137 days following an aerosol challenge with M. bovis
showed positive serological responses to ESAT6-p and
rMPB70 in the EIA, LBAA, and ICGA, respectively (Tables 3
and 4). A positive antibody response to ESAT6 was first de-
tected in samples of blood from experimentally M. bovis-in-
fected calves and deer at 27 and 90 days p.i., respectively.
Antibody activity was consistently detectable in M. bovis-in-
fected calves until 137 days p.i. in all groups except group c,
TABLE 3. Summary of serological responses of sera sampled monthly or bimonthly after inoculation from experimentally M. bovis-infected
calves in an EIA, ICGA, or LBAA utilizing rMPB70 or ESAT6-p as the capture or conjugating antigen
Sample datea
ESAT6-p rMPB70











a b c d a b c d a b c d a b c d a b c d
2 wks (	) 0 0 0 0 0/20 (0) 0 0 0 0 0/20 (0) 0 0 0 0 0/20 (0) 0 0 0 0 0/20 (0) 0 0 0 0 0/20 (0)
27 days () 3 4 4 3 14/20 (70) 2 4 5 5 16/20 (80) 0 1 0 1 2/20 (10) 2 5 1 3 11/20 (55) 0 3 0 3 6/20 (30)
78 days () 2 0 0 2 4/20 (20) 4 5 4 5 18/20 (90) 0 4 0 4 8/20 (40) 2 5 2 5 14/20 (70) 1 5 2 5 13/20 (65)
137 days () 3 0 0 3 6/20 (30) 5 0 0 3 8/20 (40) 4 5 2 5 16/20 (80) 3 5 4 5 17/20 (85) 5 5 3 5 18/20 (90)
a (	), preinfection; (), postinfection.
b Experimental M. bovis infection of 20 calves (5 calves in each of four groups) was carried out by aerosol challenge of 103 (group a) or 105 (group b) CFU of M.
bovis from white-tailed deer (1315) or 103 (group c) or 105 (group d) CFU of M. bovis from cattle (HC2005T) (40). Values are numbers of positive sera.
c Values are numbers of positive sera/numbers of sera tested, with percent sensitivity in parentheses. ESAT6-p shows a positive reaction with sera collected in the
earlier months, but rMPB70 detects positive sera collected in the later months. CMI to M. bovis tuberculin was checked by a skin test with aerosol-infected calves at
57 and 123 days postchallenge with M. bovis (40). As in other studies (27, 28), those skin tests gave a positive effect on the titer of antibody to rMPB70 but not ESAT6-p
in blood samples taken 2 and 3 weeks following the skin test.
TABLE 4. Summary of serological responses of sera sampled monthly or bimonthly after inoculation from experimentally M. bovis-infected
deer in an EIA, ICGA, or LBAA utilizing rMPB70 or ESAT6-p as the capture or conjugating antigena
Sample dateb EIA with ESAT6-p LBAA with ESAT6-p EIA with rMPB70 LBAA with rMPB70 ICGA with rMPB70
2 wks (	) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0) 0/4 (0)
90 days () 4/4 (100) 4/4 (100) 0/4 (0) 0/4 (0) 0/4 (0)
119 days () 4/4 (100) 4/4 (100) 0/4 (0) 1/4 (25) 0/4 (0)
228 days () 2/4 (50) 2/4 (50) 4/4 (100) 1/4 (25) 0/4 (0)
252 days () 0/2 (0) 0/2 (0) 2/2 (100) 0/2 (0) 0/2 (0)
309 days () 0/4 (0) 0/4 (0) 4/4 (100) 3/4 (75) 2/4 (50)
a Values are numbers of positive sera/numbers of sera/tested, with percent sensitivity in parentheses. ESAT6-p shows a positive reaction with sera collected in the
earlier month, but rMPB70 detects positive sera collected in the later month. CMI to M. bovis tuberculin was checked by a skin test with intratonsillarly M. bovis-infected
deer at 96 and 225 days postinfection (39). As in other studies (27, 28), those skin tests gave a positive effect on the titer of antibody to rMPB70 but not ESAT6-p in
blood samples taken 2 and 3 weeks following the skin test.
b (	), preinfection; (), postinfection.
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where antibody activity became less detectable by 78 days.
Animals in this group were infected with 103 CFU of M. bovis
(HC2005T, cattle strain). Antibody activity was detectable in
infected deer until 228 days p.i. In contrast to ESAT6-p, anti-
body activity to rMPB70 appeared at 27 days p.i. in calves
which were infected with 105 CFU of M. bovis (groups b and d)
and at 137 days p.i. in calves infected with 103 CFU of M. bovis
(groups a and c). Antibody was detected at 119 days p.i. in
deer. The titer of the antibody increased after its first appear-
ance, and it was still present at a high titer until the last blood
sampling day (137 and 309 days p.i. for calves and deer, re-
spectively). Infection with a low or high dose of M. bovis ap-
peared to affect the timing of when antibody responses to
ESAT6-p and rMPB70 were detectable.
In a diseased herd, infected animals must be identified and
slaughtered. This becomes difficult as skin tests are not very
sensitive and only a third of infected animals show lesions.
Small granulomas may be seen when the lymph nodes are cut
into thin sections. Animals with nonvisible lesions (NVL) are
those that are positive by skin test with no visible lesions and
M. bovis culture negative. On the other hand, the heavily in-
fected animals may not react in the skin test, a situation re-
ferred to as “anergy.” However, NVL cattle and anergic cattle
in the advanced stage of bTB exhibit a striking immunoglob-
ulin G1 memory response to rMPB70 (27, 28), as demon-
strated in the memory index ratio of antibody titer detected
before and after skin testing. It has also been shown in this
study with one of the NVL calves experimentally infected by
aerosol exposure (103 CFU of M. bovis) that showed no gross
or microscopic lesions, no response to the tuberculin skin test,
and no outgrowth of bacteria from feces, lymph nodes, and
other tissues (40). Serum from this calf was positive for
ESAT6-p in the EIA and LBAA developed in this study by day
27 p.i., and it became positive for both ESAT6-p and rMPB70
by the LBAA at 78 and 137 days p.i. Sera collected from this
NVL calf even at 137 days p.i. and from three deer out of a
total of four deer at 90 days p.i. showed ODs higher than or the
same as the determined cutoff value (0.5 for ESAT6-p and
0.045 for rMPB70) in the EIA.
Skin tests at 57 and 123 days p.i. in infected calves (40) and
at 96 and 225 days p.i. in intratonsillarly M. bovis-infected deer
(39) had a boosting effect on the titer of antibody to rMPB70,
but not ESAT6-p, in blood samples taken 2 and 3 weeks fol-
lowing a skin test, as expected (27, 28). In summary, it can be
concluded that the anti-ESAT6-p antibody titer might de-
crease during disease progression while the titer of antibody to
MPB70 increases (27). Consequently, the serological assays
(EIA, LBAA, and ICGA) developed and used in this study
should be useful in the detection of NVL cattle infected with
M. bovis early in the course of disease and later, with the use of
the memory index of antibody response to rMPB70 following
skin testing.
In the present study, we have demonstrated that the LBAA
and ICGA using ESAT6-p or rMPB70 offer the potential for
developing relatively rapid assays for detecting animals in-
fected with M. bovis. Additional advantages that LBAA and
ICGA offer are that the same assays can be used in multiple
species since no additional reagents are necessary to develop
the test and the results can be interpreted within 2 or 3 h with
the LBAA and 20 min with the ICGA. The three kinds of
rMPB70 antigens used as the capture antigens for the EIA, the
conjugated antigen with colloidal gold for the ICGA, and the
capture antigen used at the test line of the ICGA are all
different in terms of different carrier or epitopes. Moreover,
the secondary reagent, used after the reaction between serum
antibody and rMPB70 used to coat the EIA plate or rMPB70
conjugated with colloidal gold in the sample pad of the ICGA
kit, is an rMPB70-conjugated enzyme or another rMPB70 an-
tigen in each assay, respectively. This suggests that sera from
any species can be tested with the EIA and ICGA kits from
Animal Genetics Inc. These two kits can detect all of the
isotypes of anti-MPB70 antibody by enzyme reaction or anti-
gen-colloidal gold complex.
Additionally, the EIA and ICGA or LBAA detecting anti-
MPB70 antibodies have increased the sensitivity for diagnosis
of bTB to 99.7 and 100% when combined with each assay to
FIG. 3. ODs from the EIA with ESAT6-p or rMPB70 and sera
from experimentally M. bovis-infected calves (A) or deer and control
deer (B). Detailed information on how M. bovis was inoculated exper-
imentally into calves or deer and how blood was collected from them
is given in Materials and Methods. ODs from EIAs using different
capture or detecting antigens and sera from control or M. bovis-in-
fected deer are shown on the y axes (EIA using ESAT-6 on the left y
axis and EIA with rMPB70 on the right y axis [B]). D, days; wk, week.
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detect antibody to ESAT6-p. It will be worthwhile to deter-
mine if the use of a cocktail of antigens made of ESAT6-p and
rMPB70 for detecting bTB infection may be effective in iden-
tifying animals regardless of the stage of disease. Separate
assays could be subsequently used to differentiate infected
animals at the early and advanced stages of disease.
The accuracy of these combined assays or each test used in
this study, which is demonstrated as sensitivity and specificity
(Table 1), is higher than or comparable to that in other studies.
An EIA with nine purified recombinant proteins of M. tuber-
culosis complex mycobacteria, including ESAT-6 and MPB70,
could detect antibody-positive reactors composed of 16 out of
28 IFN--positive cattle from field bTB outbreaks (2). Addi-
tionally, the Mantoux test (tuberculin skin test) and the tuber-
culin IFN- assay (Quanti-FERON-TB) were reported to have
sensitivities of 87 and 83 to 90% and specificities of 80 and
98%, respectively (45). In Whipple’s study, the caudal fold
tuberculin test and IFN- assay showed sensitivities ranging
from 80.4 to 84.4% and 55.4 to 97.1%, respectively, depending
on the standard of comparison and the method of interpreta-
tion (62). According to two other different studies (5, 44),
IFN- blood tests using PPD and ESAT-6 antigen had sensi-
tivities ranging from 89 to 98% and 76 to 88%, depending on
the cutoff values used. The specificity turned out to be 85 to
94% when using PPD for the test antigen and 94 to 100% for
IFN- blood tests with ESAT-6 as the antigen.
In conclusion, serological assays, EIA, ICGA, and LBAA
utilizing ESAT6-p for early bTB detection and rMPB70 for
detection of the advanced stages of bTB, can be used with the
skin test to determine the status of disease and reduce the
frequency of misdiagnosis of animals free of bTB.
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